Skip to main content
OpenTrials
Completed

NCT Number: NCT05327712

Using Emails and Personalized Phone Calls to Increase Affordable Care Act Marketplace Enrollment Among Households Losing Medicaid

Since its passage in 2010, the Affordable Care Act (ACA) has helped reduce the uninsured rate to record lows, but changes in insurance coverage over time, known as churn, remain a concern. A recent survey found that nearly 25 percent of respondents reported a change in coverage over the previous twelve months. Among the most common reasons for churn is the loss of Medicaid eligibility, placing low-income populations at risk of a coverage gap. To date, little evidence exists on effective strategies states can use to facilitate Medicaid to Marketplace coverage transitions, an issue that has become more pressing amid projections that upwards of 15 million people could lose Medicaid eligibility once the COVID-19 public health emergency expires.

To address this gap and to inform Marketplace administrators, during a Special Enrollment Period (SEP) in 2017 in California's ACA Marketplace, we conducted a randomized controlled trial to examine the effect of email reminders, personalized telephone outreach, as well as the combination of the two forms of outreach on ACA enrollment among households who recently lost Medicaid and became eligible for subsidized Marketplace coverage.

During the SEP at the end of August 2017, the investigators randomly assigned households to one of four arms based on the last digit of their household identifier: a control group assigned to receive no outreach beyond an initial eligibility determination notice; an email-only group assigned to receive an initial eligibility determination plus email reminders about signing up for marketplace coverage; a phone-only group assigned to receive an initial eligibility determination plus a phone call offering enrollment assistance from a service center representative (SCR); a phone + email group assigned to receive an initial eligibility determination, email reminders about signing up for marketplace coverage and a phone call offering enrollment assistance.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Covered California

Sacramento, California, 95815, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Those who recently lost Medicaid eligibility and became eligible for subsidized Affordable Care Act coverage

Exclusion criteria

  • Those who recently lost Medicaid eligibility and were found ineligible for subsidies.

Treatment and study plan

Control Group

Behavioral

No outreach during the intervention period beyond an initial eligibility notice.

Other names: No outreach

Email only

Behavioral

Email reminders in addition to an initial eligibility notice.

Phone only

Behavioral

Phone call offering enrollment assistance in addition to an initial eligibility notice.

Phone and email

Behavioral

Phone call and email reminders in addition to an initial eligibility notice.

Primary outcomes

  1. Percent of households enrolled in an ACA plan by the end of the October 2017

    Time frame: Two months

    Percent of households enrolled in an ACA plan during the intervention period

Sponsors and collaborators

Lead sponsor

Office of Evaluation Sciences

Fed

Registry information

Important dates

Study start
2017
Primary completion
2017
Study completion
2017
First posted
Apr 14, 2022
Registry last updated
Jun 16, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.